Recruiting Clinical Trials

Displaying 71 - 80 of 213 result(s)
Study Title Condition Phase Location
A Randomized, Placebo-controlled, Investigator- and Participant-blinded Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation Atrial Fibrillation Phase 2
  • Country: 
    United States
  • Country: 
    Germany
A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319 Heart Failure Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Austria
  • Country: 
A Randomized, Multicenter, Active-comparator Controlled, Open-label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult Patients With PNH and Residual Anemia, Despite Treatment With an Intravenous Anti-C5 Antibody. Paroxysmal Nocturnal Hemoglobinuria (PNH) Phase 3
  • Country: 
    United States
  • Country: 
    Brazil
  • Country: 
    Czech Republic
  • Country: 
An Open Label, Multi-center Phase IIIb Study of Asciminib (ABL001) Monotherapy in Previously Treated Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation Chronic Myelogenous Leukemia - Chronic Phase Phase 3
  • Country: 
    United States
A Randomized, Double-blind, Phase III Study, Comparing NIS793 in Combination With Gemcitabine and Nab-paclitaxel Versus (vs.) Placebo Combined With Gemcitabine and Nab-paclitaxel for First Line Treatment of Metastatic Pancreatic Ductal Adenocarcinoma ... Metastatic Pancreatic Ductal Adenocarcinoma Phase 3
  • Country: 
    Australia
  • Country: 
    Japan
A Randomized, Placebo-controlled, Patient and Investigator Blinded, Study Investigating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Doses of CFZ533 in Patients With Moderately Active Proliferative Lupus Nephritis Lupus Nephritis Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    China
  • Country: 
A Phase Ib, Open-label, Multicenter Study of Oral LXH254-centric Combinations in Adult Patients With Advanced or Metastatic KRAS or BRAF Mutant Non-Small Cell Lung Cancer or NRAS Mutant Melanoma Non-Small Cell Lung Cancer, Melanoma Phase 1
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
A One-year, Single-arm, Open-label, Multicenter Study Assessing the Effect of Brolucizumab on Disease Control in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration (SWIFT) Neovascular Age-Related Macular Degeneration Phase 3
  • Country: 
    France
A Phase IIIb, Open-label, Single-arm, Single-dose, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of Gene Replacement Therapy With Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) Spinal Muscular Atrophy Phase 3
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
    Canada
  • Country: 
A Randomized, Active-controlled, Patient and Investigator-masked, Multiple Dose Proof-of-concept Study of Intravitreal LKA651 in Patients With Diabetic Macular Edema Diabetic Macular Edema Phase 2
  • Country: 
    United States
  • Country: 
    Germany
  • Country: 
    Puerto Rico
  • Country: